NHS to offer second MenB vaccine after deadly Kent outbreak
NHS to Offer Second MenB Vaccine Following Kent Outbreak
The NHS is set to administer a second dose of the meningitis B vaccine to nearly 12,000 individuals in Kent who received the first shot after a recent outbreak. This measure aims to ensure full protection against the disease, which has claimed two lives and infected 19 others in the region. The second dose will be available starting next week, with clinics opening in Canterbury, Faversham, and Ashford.
Outbreak Response
The vaccination drive targets those potentially exposed to the bacteria, including university students and schoolchildren. Public health officials emphasized that two doses are necessary for optimal immunity, with the second dose required at least four weeks after the first. Eligible individuals can book appointments through an online system, with more details to be released from Monday.
Among those receiving the jabs are students from university residences and attendees of a nightclub linked to the outbreak. NHS Kent and Medway confirmed the rollout will span multiple sites, ensuring accessibility for affected groups. The vaccine’s efficacy covers most meningococcal group B strains in the UK, though its distribution has expanded beyond the initial focus.
Vaccination Strategy
The outbreak prompted the UK Health Security Agency to declare a national incident, enabling the allocation of resources like antibiotics. Initially, the program targeted students in Kent’s university halls, later including attendees of Club Chemistry, where the infection likely began. Additional groups, such as sixth form students at schools with confirmed cases, were also added to the list.
Preventative antibiotics were given to a broader population, with long queues observed at the University of Kent over several days. This action highlighted the urgency of the situation. While the MenB vaccine was routinely offered to babies and children since 2015, UK advisers previously deemed a catch-up campaign for teenagers cost-effective. Teenagers instead receive the MenACWY vaccine, which guards against four bacterial types but excludes MenB.
Revisiting the Decision
Health Secretary Wes Streeting called the outbreak “unprecedented” due to its rapid spread. He directed experts from the Joint Committee on Vaccination and Immunisation to reassess the earlier decision to exclude teenagers from MenB vaccination. Juliette Kenny, a sixth form pupil, and a 21-year-old university student, whose identity remains undisclosed, succumbed to the disease, while others required hospital care.
The NHS’s response underscores the importance of updated immunisation strategies in light of evolving public health threats. With the second dose now underway, officials aim to bolster community immunity and prevent further cases in the region.
